Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Slavin

Showing results (351-360 of 436) with videos related to

Pageof 44
Sort By:
Leukemia Research|August 26, 1998
Tumorigenicity and immunogenicity in a murine model of B-cell leukemia/lymphoma (BCL1)S Morecki, A Nagler, Z Zakay-Rones, et al.
Current Molecular Medicine|April 18, 2013
Oxidative stress protection by novel telomerase activators in mesenchymal stem cells derived from healthy and diseased individualsA Tichon, E Eitan, B G Kurkalli, et al.
Transplantation|June 1, 1987
Bone marrow transplantation with T-cell-depleted grafts. II. Reconstitution of immunohemopoietic functions in lethally irradiated mice transplanted with unseparated or T-cell-depleted bone marrow grafts disparate at minor histocompatibility antigensB Leshem, B Z Tsuberi, Z Lebendiker, et al.
British Journal of Cancer|August 18, 2005
Salvage high-dose chemotherapy for children with extragonadal germ-cell tumoursU De Giorgi, G Rosti, S Slavin, et al.
Blood|October 15, 1995
Analysis of beta-globin mutations shows stable mixed chimerism in patients with thalassemia after bone marrow transplantationJ Kapelushnik, R Or, D Filon, et al.
Bone Marrow Transplantation|December 1, 1996
Activated allogeneic cell therapy (allo-ACT) for relapsed chronic myelogenous leukemia (CML) refractory to buffy coat transfusions post-allogeneic bone marrow transplantationJ Kapelushnik, A Nagler, R Or, et al.
Israel Journal of Medical Sciences|March 1, 1988
Prevention of herpes simplex virus (HSV) infection in recipients of HLA-matched T-lymphocyte-depleted bone marrow allograftsD Engelhard, A Morag, R Or, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
The antiangiogenic agent linomide inhibits the growth rate of von Hippel-Lindau paraganglioma xenografts to miceD J Gross, I Reibstein, L Weiss, et al.
Transplantation|February 15, 1996
Nosocomial coagulase-negative staphylococcal infections in bone marrow transplantation recipients with central vein catheter. A 5-year prospective studyD Engelhard, H Elishoov, N Strauss, et al.
Bone Marrow Transplantation|October 1, 1991
Immune response to polio vaccination in bone marrow transplant recipientsD Engelhard, R Handsher, E Naparstek, et al.
Pageof 44

Showing results (351-360 of 436) with videos related to

Sort By:
Pageof 44
Leukemia Research|August 26, 1998
Tumorigenicity and immunogenicity in a murine model of B-cell leukemia/lymphoma (BCL1)S Morecki, A Nagler, Z Zakay-Rones, et al.
Current Molecular Medicine|April 18, 2013
Oxidative stress protection by novel telomerase activators in mesenchymal stem cells derived from healthy and diseased individualsA Tichon, E Eitan, B G Kurkalli, et al.
Transplantation|June 1, 1987
Bone marrow transplantation with T-cell-depleted grafts. II. Reconstitution of immunohemopoietic functions in lethally irradiated mice transplanted with unseparated or T-cell-depleted bone marrow grafts disparate at minor histocompatibility antigensB Leshem, B Z Tsuberi, Z Lebendiker, et al.
British Journal of Cancer|August 18, 2005
Salvage high-dose chemotherapy for children with extragonadal germ-cell tumoursU De Giorgi, G Rosti, S Slavin, et al.
Blood|October 15, 1995
Analysis of beta-globin mutations shows stable mixed chimerism in patients with thalassemia after bone marrow transplantationJ Kapelushnik, R Or, D Filon, et al.
Bone Marrow Transplantation|December 1, 1996
Activated allogeneic cell therapy (allo-ACT) for relapsed chronic myelogenous leukemia (CML) refractory to buffy coat transfusions post-allogeneic bone marrow transplantationJ Kapelushnik, A Nagler, R Or, et al.
Israel Journal of Medical Sciences|March 1, 1988
Prevention of herpes simplex virus (HSV) infection in recipients of HLA-matched T-lymphocyte-depleted bone marrow allograftsD Engelhard, A Morag, R Or, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
The antiangiogenic agent linomide inhibits the growth rate of von Hippel-Lindau paraganglioma xenografts to miceD J Gross, I Reibstein, L Weiss, et al.
Transplantation|February 15, 1996
Nosocomial coagulase-negative staphylococcal infections in bone marrow transplantation recipients with central vein catheter. A 5-year prospective studyD Engelhard, H Elishoov, N Strauss, et al.
Bone Marrow Transplantation|October 1, 1991
Immune response to polio vaccination in bone marrow transplant recipientsD Engelhard, R Handsher, E Naparstek, et al.
Pageof 44